Advertisement
New details surfaced on Thursday on an unexplained neurological condition that struck a volunteer who was participating in AstraZeneca's COVID-19 vaccine trial.

Details Emerge on Unexplained Illness in AstraZeneca COVID-19 Vaccine Trial

0
Healthy 37-year-old woman 'experienced confirmed transverse myelitis' after receiving second dose of vaccine
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 14 to 18

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
When a safe and effective vaccine against COVID-19 becomes available

Vaccine Campaign Would Take Six to Nine Months to Curb COVID-19

0
First to be vaccinated would be those with health conditions that make them vulnerable to severe illness, death
Of those aged younger than 21 years with deaths associated with severe acute respiratory syndrome coronavirus 2

Characteristics ID’d for Under 21s With SARS-CoV-2-Linked Deaths

0
Teens and young adults, those with underlying medical conditions overrepresented among decedents
A single infusion of an experimental drug dramatically lowers levels of coronavirus in the bodies of newly infected patients and cuts their chances of hospitalization

New Drug Shows Promise in Preventing Severe COVID-19

0
Drug is monoclonal antibody, a man-made copy of antibody produced by a recovered COVID-19 patient
Most doctors hold misperceptions about the risks of nicotine

Many Doctors Misinformed About Nicotine’s Risks

0
Less than one-third of doctors correctly agree that nicotine directly contributed to birth defects
Factor V activity is significantly increased in patients with severe COVID-19

Factor V Activity Significantly Increased in Severe COVID-19

0
Rates of DVT/PE significantly higher for patients with COVID-19 and elevated factor V activity
In a sign that Americans are becoming more wary about the safety of a COVID-19 vaccine

Poll: Most Americans Do Not Trust Trump’s COVID-19 Vaccine Comments

0
More than half of adults say they do not trust the president's vaccine comments
Two of three planned adaptive phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19 have launched

NIH Launches Clinical Trials of Antithrombotics for COVID-19

0
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients
More than 83 percent of overdose deaths during January to June 2019 involved illicitly manufactured fentanyls

One or More Opioids Involved in ~80 Percent of OD Deaths

0
At least one potential opportunity for prevention intervention for 62.7 percent of overdose deaths